BCM
Boxer Capital Management Portfolio holdings
AUM
$199M
This Quarter Return
-6.27%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$332M
AUM Growth
+$332M
(-72%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-222.23%
Top 10 Holdings %
Top 10 Hldgs %
72.35%
Holding
62
New
2
Increased
2
Reduced
10
Closed
34
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$4.59M |
| 2 |
Denali Therapeutics
DNLI
|
$3.4M |
| 3 |
Prelude Therapeutics
PRLD
|
$308K |
| 4 |
Kodiak Sciences
KOD
|
$98.4K |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$124M |
| 2 |
Revolution Medicines
RVMD
|
$105M |
| 3 |
Merus
MRUS
|
$50.5M |
| 4 |
Nuvalent
NUVL
|
$47.5M |
| 5 |
Axsome Therapeutics
AXSM
|
$39.8M |
Sector Composition
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.1B
| $46.6M | 14.02% | 1,317,977 -2,961,487 | -69% | -$105M |
|
|
2
Nuvalent
NUVL
$5.52B
| $31.9M | 9.6% | 450,000 -670,192 | -60% | -$47.5M |
|
|
3
Merus
MRUS
$4.98B
| $29.5M | 8.86% | 700,000 -1,200,000 | -63% | -$50.5M |
|
4
Avidity Biosciences
RNA
$5.99B
| $25.5M | 7.68% | 865,000 -862,388 | -50% | -$25.5M |
|
5
AnaptysBio
ANAB
$569M
| $24.2M | 7.27% | 1,300,000 | – | – |
|
6
Xenon Pharmaceuticals
XENE
$2.98B
| $20.1M | 6.05% | 600,000 | – | – |
|
7
Replimune Group
REPL
$422M
| $17.5M | 5.27% | 1,796,341 | – | – |
|
8
Apellis Pharmaceuticals
APLS
$3.48B
| $15.6M | 4.69% | 713,000 -713,000 | -50% | -$15.6M |
|
|
CMRX
9
DELISTED
Chimerix, Inc.
CMRX
| $15.4M | 4.63% | 1,810,000 -250,000 | -12% | -$2.13M |
|
10
Tango Therapeutics
TNGX
$747M
| $14.2M | 4.28% | 10,380,999 | – | – |
|
11
Enliven Therapeutics
ELVN
$1.2B
| $13.2M | 3.97% | 671,358 | – | – |
|
12
Oric Pharmaceuticals
ORIC
$994M
| $9.67M | 2.91% | 1,732,571 | – | – |
|
13
Day One Biopharmaceuticals
DAWN
$769M
| $9.44M | 2.84% | 1,189,943 | – | – |
|
14
Kymera Therapeutics
KYMR
$2.95B
| $8.9M | 2.68% | 325,000 -100,000 | -24% | -$2.74M |
|
15
Prothena Corp
PRTA
$441M
| $8.54M | 2.57% | 690,000 | – | – |
|
16
uniQure
QURE
$896M
| $7.95M | 2.39% | 750,000 | – | – |
|
17
Legend Biotech
LEGN
$6.41B
| $6.79M | 2.04% | 200,000 -500,000 | -71% | -$17M |
|
18
Nurix Therapeutics
NRIX
$714M
| $6.69M | 2.01% | 563,067 | – | – |
|
19
Amylyx Pharmaceuticals
AMLX
$836M
| $6.2M | 1.86% | 1,750,000 | – | – |
|
|
20
Solid Biosciences
SLDB
$427M
| $4.59M | 1.38% | +1,240,700 | New | +$4.59M |
|
|
21
Denali Therapeutics
DNLI
$2.23B
| $3.4M | 1.02% | +250,000 | New | +$3.4M |
|
|
22
Kodiak Sciences
KOD
$478M
| $2.91M | 0.87% | 1,035,000 +35,000 | +4% | +$98.4K |
|
|
23
Prelude Therapeutics
PRLD
$68.5M
| $1.62M | 0.49% | 2,108,014 +399,827 | +23% | +$308K |
|
24
Instil Bio
TIL
$182M
| $1.39M | 0.42% | 80,125 -275,375 | -77% | -$4.78M |
|
|
BOLD
25
Boundless Bio
BOLD
$25.1M
| $378K | 0.11% | 250,000 | – | – |
|